Company Login
Site Newsletter
Welcome to PharmiWeb.com
Latest Press Releases
- Hallmark Health System Selects Simplifi 797 to Help with USP Chapter 797 Compliance
03 Jul 08
- Thermo Fisher Scientific and Evonik Industries Cooperate to Advance Hot Melt Extrusion
03 Jul 08
- DataLase press release:
03 Jul 08
The Scott Partnership - Piribo: PAREXEL's Bio/Pharma R&D Statistical Sourcebook 2008/2009 now available
03 Jul 08
Piribo - Shire to add new orphan drug to its HGT portfolio EU launch imminent
03 Jul 08
Latest News
Reports of China drug clean up for OlympicsMarketletter Publications
05 Jul 08 , 01:19
Teva reduces price of its offer for BentleyMarketletter Publications
05 Jul 08 , 01:19
AstraZeneca reinforces reputationInternational Financing Review
05 Jul 08 , 01:18
Polish watchdog clears Richter buy of PolpharmaReuters Health
05 Jul 08 , 00:48
Need to know: GSK appeal ... BHP wins price rise ... UBS in troubleThe Times
04 Jul 08 , 23:17
Latest Events
- EU PHARMACEUTICAL REGULATIONS
07 Jul 08 - 08 Jul 08 - BASIC INTRODUCTION TO INTELLECTUAL PROPERTY
07 Jul 08 - 07 Jul 08 - Effective Standard Operating Procedures: A Complete and Successful Approach Live Web Training Series
07 Jul 08 - 21 Jul 08
pharmiweb.com today | 05 July 2008
More Than 500 Backlogged Whistle-Blower Cases Allege Health Care, Drug Company Fraud
Whistle-blower lawsuits alleging that pharmaceutical companies and government contractors defrauded the federal government have created a backlog of more than 900 cases at the Department of Justice, the Washington Post reports. According to the Post, more than 500 of the cases involve the health care and pharmaceutical industries, as well as Medicare and Medicaid.
Lawyers involved in the backlogged disputes say DOJ "cannot keep pace with the surge in charges brought by whistle-blowers," the Post reports. Since 2001, 300 to 400 civil cases have been filed each year; however, the 75-lawyer unit that reviews the allegations investigates about 100 cases annually. Whistle-blowers routinely wait 14 or more months to find out whether DOJ will get involved in the case, during which time whistle-blowers are not allowed to discuss or disclose the existence of such disputes.
Latest Features
The US Drug Approval Trends and Yearbook
27 Jun 08
Finally a comprehensive source for the very latest performance metrics and trend analysis on every key aspect of the new drug approval processThe US Drug Approval Trends and Yearbook 2006/2007!
Negative Pressure Wound Therapy.
23 Jun 08
In recent years Negative Pressure Wound Therapy has revolutionised the way clinicians manage and treat a wide range of wounds, Negative Pressure Wound Therapy (NPWT) is a mechanical wound care treatment...
New generation anti-TNF drug Cimzia (certolizumab pegol) may offer faster control of RA
17 Jun 08
Cimzia (certolizumab pegol) is the first and so far, only, PEGylated, Fc-Free, anti-tumour necrosis factor (TNF) alpha treatment in development for rheumatoid arthritis.
Latest Poll
